SYCP3

SYCP3 is a core structural component of the synaptonemal complex lateral element that organizes meiotic chromosomes by bridging distant DNA sites to compact chromatin and by maintaining cohesin-core integrity during meiotic prophase I. The protein forms a helical tetramer with N-terminal DNA-binding domains at each end, enabling it to act as a molecular strut that compacts DNA; polymerization into flexible fibres is driven by a conserved coiled-coil domain and flanking CM motifs, with inter-molecular contacts mediated by intrinsically disordered tails rather than helical cores (PMID:24950965, PMID:28287952, PMID:31615332, PMID:18391527). Timely SYCP3 turnover during pachytene is controlled by FBXW24-mediated ubiquitination, and translational activation of Sycp3 mRNA in germ cells depends on DAZL; loss-of-function or dominant-negative C-terminal mutations cause azoospermia or recurrent pregnancy loss (PMID:35858239, PMID:17526644, PMID:14643120, PMID:19110213). When aberrantly expressed in mitotic cells, SYCP3 directly complexes with BRCA2 and inhibits RAD51-mediated homologous recombination, inducing chromosomal instability (PMID:22116401).

1. 2003 High

   Establishing that SYCP3 loss-of-function mutations cause human infertility: a truncating mutation removing the C-terminal coiled-coil domain acted as a dominant negative to disrupt SYCP3 fibre formation, linking SYCP3 directly to azoospermia.

   Evidence Patient mutation sequencing, in vitro protein interaction assay, and transfection/immunofluorescence in cultured cells

   PMID:14643120

   Open questions at the time

   • Mechanism of dominant-negative interference at the polymer level was not resolved
   • No in vivo meiotic phenotype characterized for this mutation
2. 2004 High

   Defining SYCP3's role in synapsis and chromatin-loop organization: Sycp3-null male mice showed failure of intimate homologue synapsis and aberrant chromatin-loop attachment, establishing that SYCP3 specifies selective loop-axis organization rather than homology alignment.

   Evidence Sycp3-knockout mouse, FISH, chromatin-loop measurement, transgene localization

   PMID:15237206

   Open questions at the time

   • Whether SYCP3 acts directly or through SYCP2 in loop selectivity was not separated
   • Female meiotic phenotype not addressed in this study
3. 2005 High

   Revealing SYCP3's function in maintaining cohesin integrity: in Sycp3-knockout females, cohesin cores disassembled prematurely at diplotene, showing SYCP3 stabilizes but does not establish cohesin organization.

   Evidence Sycp3-knockout mouse female oocytes, immunofluorescence of cohesin proteins

   PMID:15870106

   Open questions at the time

   • Molecular interface between SYCP3 and cohesin subunits was not identified
   • Whether the same mechanism operates in male meiosis was not tested
4. 2007 High

   Identifying translational control of SYCP3 and the domain requirements for polymerization: DAZL was shown to bind Sycp3 mRNA and activate its translation, while systematic deletion mapping defined the alpha-helical domain and CM motifs as necessary and sufficient for higher-order assembly.

   Evidence RNA immunoprecipitation, in vitro translation, Dazl-knockout Western blot; domain-deletion constructs with cellular polymerization readout

   PMID:17526644 PMID:18391527

   Open questions at the time

   • DAZL binding site on Sycp3 mRNA was not mapped at nucleotide resolution
   • How CM motifs mediate inter-molecular contacts was unknown
5. 2008 High

   Extending disease association to recurrent pregnancy loss: C-terminal splicing mutations produced truncated SYCP3 proteins that co-assembled with wild-type and dominantly inhibited fibre formation, broadening the clinical spectrum of SYCP3 mutations.

   Evidence Minigene splicing assay, in vitro interaction assay, co-expression immunofluorescence

   PMID:19110213

   Open questions at the time

   • No direct meiotic analysis was possible in patient oocytes
   • Population frequency and penetrance of these mutations were not established
6. 2011 High

   Discovering a cancer-relevant gain-of-function: aberrant SYCP3 expression in mitotic tumour cells directly complexed with BRCA2, inhibited RAD51-mediated homologous recombination, and sensitized cells to PARP inhibitors, establishing a mechanism for chromosomal instability.

   Evidence Reciprocal co-immunoprecipitation, HR repair assays (RAD51 foci, gene conversion), PARP inhibitor sensitivity in cancer cell lines

   PMID:22116401

   Open questions at the time

   • The BRCA2-binding interface on SYCP3 was not mapped
   • Whether SYCP3 expression predicts PARP inhibitor response in patients was not tested
7. 2014 High

   Solving the atomic structure: SYCP3 was shown to form a 20 nm helical tetramer with N-terminal DNA-binding ends projecting from each side, directly explaining how it can bridge distant chromosomal DNA sites and self-assemble into lateral-element-like filaments.

   Evidence X-ray crystal structure, in vitro reconstitution, electron microscopy

   PMID:24950965

   Open questions at the time

   • Structure captured the core domain only; N-terminal and disordered tail regions were unresolved
   • How tetramers interact to form higher-order fibres was not determined
8. 2017 High

   Directly visualizing DNA compaction at the single-molecule level: optical tweezers experiments confirmed that SYCP3 bridges distant sites on a single DNA molecule, mechanistically validating the structural strut model.

   Evidence Single-molecule optical tweezers, fluorescence microscopy, microfluidics

   PMID:28287952

   Open questions at the time

   • Compaction was studied on naked DNA; contribution of chromatin context was not assessed
   • Cooperative effects of multiple SYCP3 molecules bridging the same DNA were not quantified
9. 2019 High

   Resolving fibre architecture: cryo-ET revealed that SYCP3 fibres are built from irregularly arranged molecules held together through intrinsically disordered tails with no helical-core contacts, explaining the flexibility of lateral element filaments.

   Evidence Cryo-electron tomography, atomic force microscopy, in vitro DNA-binding assays

   PMID:31615332

   Open questions at the time

   • In vivo validation of the irregular fibre architecture was not performed
   • How SYCP2 integrates into the fibre was not addressed
10. 2022 High

    Identifying the degradation pathway: FBXW24 was shown to directly ubiquitinate SYCP3 for timely turnover during pachytene; failure to degrade SYCP3 caused DNA damage accumulation, reduced crossovers, and female infertility.

    Evidence Co-IP, in vivo/in vitro ubiquitination assays, mass spectrometry of ubiquitination sites, Fbxw24-knockout mouse phenotyping

    PMID:35858239

    Open questions at the time

    • Whether additional E3 ligases contribute to SYCP3 turnover was not explored
    • Proteasomal versus non-proteasomal degradation route was not distinguished
11. 2025 Medium

    Mapping genome-wide chromatin occupancy: ChIP-seq revealed SYCP3 binds open chromatin regions from leptotene through pachytene, enriched at SINE repeats, with SYCP1-occupied sites forming a cohesin-enriched subset of SYCP3-occupied regions.

    Evidence ChIP-seq in mouse spermatocytes integrated with ATAC-seq and cohesin ChIP-seq

    PMID:40488283

    Open questions at the time

    • Causal relationship between SYCP3 binding and chromatin accessibility was not established
    • Functional significance of SINE-element enrichment is unknown
    • Independent replication in another species or lab is lacking

• Key unresolved questions include the structural basis of the SYCP3–SYCP2 interaction within the lateral element, the molecular interface between SYCP3 and BRCA2, and whether SYCP3's genome-wide chromatin occupancy pattern is functionally linked to loop-axis organization and crossover control.
• No co-crystal or cryo-EM structure of SYCP2–SYCP3 complex exists
• BRCA2-binding domain on SYCP3 has not been mapped
• Causal link between chromatin occupancy and recombination outcomes is untested